
1. Euro Surveill. 2021 Oct;26(43). doi: 10.2807/1560-7917.ES.2021.26.43.2100978.

A large-scale outbreak of hand, foot and mouth disease, France, as at 28
September 2021.

Mirand A(1)(2), Cohen R(3), Bisseux M(1)(2), Tomba S(2), Sellem FC(4), Gelbert
N(4), Béchet S(3), Frandji B(5), Archimbaud C(1)(2), Brebion A(1), Chabrolles
H(1)(2), Regagnon C(1), Levy C(3), Bailly JL(1)(2), Henquell C(1)(2).

Author information: 
(1)CHU Clermont-Ferrand, Laboratoire de Virologie, Centre National de Référence
des entérovirus et parechovirus - Laboratoire Associé, Clermont-Ferrand, France.
(2)Université d'Auvergne, LMGE UMR CNRS 6023 Equipe EPIE - Epidémiologie et
physiopathologie des infections à entérovirus, Faculté de Médecine,
Clermont-Ferrand, France.
(3)Association Clinique et Thérapeutique Infantile du Val de Marne (ACTIV),
Créteil, France.
(4)Association Française de Pédiatrie Ambulatoire (AFPA), Orléans, France.
(5)CompuGroup Medical France, Nanterre, France.

We report a large-scale outbreak of hand, foot and mouth disease (HFMD) in
France. As at 28 September 2021, 3,403 cases have been reported (47% higher than 
in 2018-19). We prospectively analysed 210 clinical samples; 190 (90.5%) were
enterovirus-positive. Most children presented with atypical HFMD. Coxsackievirus 
(CV)A6 (49.5%; 94/190) was predominant; no enterovirus A71 was detected.
Dermatological and neurological complications of HFMD justify prospective
syndromic and virological surveillance for early detection of HFMD outbreaks and 
identification of associated types.

DOI: 10.2807/1560-7917.ES.2021.26.43.2100978 
PMCID: PMC8555367
PMID: 34713796  [Indexed for MEDLINE]

